Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation
Clinical trial NCT02210065 · COMPLETED
Trial details
- NCT number
- NCT02210065
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-03
- Primary completion
- 2019-05-13
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.